Serbia spent RSD 42.47 billion in budget funds on research and development in 2025, marking an 8.9% increase from the previous year and keeping public R&D allocations at 0.41% of GDP. The number is not large enough to change Serbia’s innovation profile on its own, but it confirms a steady fiscal commitment to science at a time when the country is trying to move from a low-cost industrial and services platform toward a more technology-intensive growth model.
The Statistical Office of the Republic of Serbia reported that budget spending for research and development reached RSD 42,465,727 thousand in 2025. At an exchange rate of around RSD 117.38 per euro, that is roughly €360 million. For an economy of Serbia’s size, the level remains modest by European innovation standards, but the increase is still important because it shows that science funding is becoming a more stable budget category rather than a discretionary line vulnerable to annual fiscal pressure.
The deeper question is not whether Serbia is spending more on science. It is whether the structure of that spending can support industrial upgrading, export competitiveness and higher-value employment. Serbia has spent the past decade attracting foreign direct investment into automotive components, electronics, machinery, ICT, shared-service centres, food processing and selected advanced manufacturing. That model has delivered jobs and export growth, but the next phase depends increasingly on domestic research capacity, engineering depth, applied innovation and stronger links between universities, institutes and companies.
The current allocation still leans heavily toward the public system. The government sector received 65.1% of budget funds, while higher education received 24%. The private non-profit sector accounted for 6.1%, the non-financial business sector only 3.6%, and the foreign sector 1.2%. That distribution shows Serbia’s R&D ecosystem remains state-centred. Public institutes, universities and government-backed programmes still dominate the formal funding channel, while the direct budget link to corporate research remains narrow.
This is not unusual for a country still building its innovation base, but it does define the next policy challenge. Public money can finance laboratories, salaries, institutional capacity and basic research, but industrial transformation requires a stronger route from research to commercial application. Serbia’s science budget becomes economically more powerful when it helps companies develop patents, prototypes, process improvements, new materials, software products, agri-tech solutions, energy technologies and exportable intellectual property.
The purpose structure of spending shows where the state’s priorities currently sit. The largest share, 33.7%, went to the general advancement of knowledge funded through university channels. This is the traditional backbone of scientific development, and it remains essential because no innovation system can function without basic research, academic capacity and a pipeline of trained researchers. But from an investor and industrial-policy perspective, the more interesting category is industrial production and technology, which accounted for 15.5% of budget R&D funds.
That 15.5% allocation matters because it connects science policy with Serbia’s manufacturing base. The country already hosts a broad set of foreign and domestic industrial companies, but much of the value chain still sits in production rather than product ownership, design, R&D or platform technology. Larger public allocations toward industrial technology can help shift that position, especially if funding is tied to applied research, company partnerships, testing facilities, digitalisation, automation, materials science and energy-efficiency solutions.
Agriculture accounted for 11.5% of budget R&D spending, which is strategically relevant for Serbia because agriculture and food processing remain among the country’s most important domestic sectors. The opportunity is not only higher yields. It is precision agriculture, seed development, irrigation technology, food safety systems, bioeconomy applications, logistics, processing quality and export certification. In a country with strong agricultural potential but uneven productivity, research spending can become a direct competitiveness tool if it is linked to farms, processors, input suppliers and export markets.
At the other end of the scale, space research and exploitation accounted for only 0.4%. That low share is unsurprising, but it also shows Serbia is still concentrating science spending on more conventional institutional and industrial priorities. For now, the more immediate economic return is likely to come from applied industrial technologies, ICT, agriculture, health sciences, environmental technologies and energy systems rather than frontier space-sector development.
The comparison with total R&D expenditure gives the budget data more context. Serbia’s total R&D spending in 2024 amounted to RSD 90.58 billion, equal to 0.94% of GDP. That means public budget allocations are a large but not complete part of the national research system. Private-sector investment, institutional own revenues, international funds and other sources also matter. The long-term policy objective should be to make the public budget a catalyst for wider private and international R&D financing, not merely the main source of institutional support.
This is where Serbia’s innovation policy intersects with EU integration. The European Union’s research and innovation framework places strong emphasis on R&D intensity, Horizon-style cooperation, university-industry partnerships, digital transformation, green technologies and technology transfer. Serbia’s ability to absorb EU research funds, participate in cross-border projects and build credible innovation institutions will become more important as the accession process advances. Public R&D spending is therefore not only a domestic budget issue. It is part of Serbia’s alignment with the European knowledge economy.
The gap remains significant. EU R&D intensity is above 2% of GDP, while Serbia’s total R&D expenditure is still around 1% of GDP, and budget funds for R&D stand at 0.41% of GDP. Serbia does not need to match the most advanced EU economies immediately, but it does need a clearer path from public science financing to measurable commercial and industrial outcomes. Otherwise, higher budget allocations risk remaining inside institutions without creating enough spillover into productivity, exports and private investment.
The private-sector signal is still weak. With the non-financial business sector receiving only 3.6% of budget R&D funds, Serbia’s public financing architecture appears to have limited direct exposure to company-led research. That does not mean companies are not investing in innovation through their own budgets, especially in ICT and foreign-owned manufacturing. But it does suggest that state R&D money is not yet being used aggressively enough as a co-financing lever for corporate innovation.
A stronger model would connect public science funding to industrial clusters around Belgrade, Novi Sad, Niš, Kragujevac, Čačak and other technology or manufacturing centres. Serbia already has the building blocks: universities, science and technology parks, ICT companies, automotive suppliers, engineering faculties, research institutes and a growing base of export-oriented manufacturers. The challenge is coordination. The budget increase is useful, but the return depends on whether projects are selected, monitored and commercialised with discipline.
The labour-market dimension is equally important. Serbia faces the same pressure as much of Central and Southeast Europe: skilled engineers, researchers and IT specialists are internationally mobile. Higher science funding can help retain talent, but only if it supports credible research careers, modern equipment, international collaboration and private-sector pathways. Young researchers will not stay because a budget line increases. They will stay if the ecosystem offers laboratories, grants, competitive salaries, company partnerships and visible career progression.
The increase in 2025 also needs to be read against broader fiscal priorities. Serbia is financing infrastructure, energy projects, defence, public wages, pensions and preparations for major events such as EXPO 2027. In that environment, an 8.9% rise in science spending shows that R&D has not been pushed aside. But it also means the science budget must justify itself through clearer performance indicators. The state will increasingly need to show how public R&D spending supports patents, technology transfer, start-ups, export capacity, climate adaptation, productivity and industrial upgrading.
For investors, the data is a useful signal but not yet a decisive one. Serbia’s attraction as an investment location has traditionally rested on labour cost, location, incentives, logistics, free-trade access and a growing services base. A stronger science and R&D system would add a different layer: the ability to support higher-value operations rather than only production, assembly or outsourced services. That is the shift Serbia needs if it wants to compete for engineering centres, product development, applied AI, industrial software, biotech, energy technologies and advanced materials.
The budget figure of RSD 42.47 billion should therefore be seen as part of a larger economic transition. Serbia is not yet an innovation-led economy, but it is no longer operating only as a lower-cost production base. The country is trying to build the institutions and funding channels that allow knowledge, engineering and research to play a bigger role in growth. The challenge is that institutional spending rises faster than measurable market impact unless governance, incentives and private-sector integration are improved.
The planned figure for 2026, before any budget revision, was reported at RSD 42.3 billion, broadly in line with the 2025 level. That points to continuity rather than a major new acceleration. Continuity is valuable, because research systems need predictable financing. But Serbia’s next step should be more ambitious in structure rather than only volume: more competitive grants, stronger university-company consortia, clearer industrial missions, better technology-transfer offices, stronger IP commercialisation and deeper integration with European research networks.
The latest data shows a country increasing science spending, but still searching for the economic mechanism that turns public R&D into private-sector value. Serbia’s science budget is becoming larger and more stable. Its strategic importance will depend on whether that money remains mainly institutional support or becomes a real lever for industrial competitiveness, talent retention and higher-value growth.
